Heart-type, fatty-acid binding protein can be a diagnostic marker in acute coronary syndromes

Journal of the National Medical Association

Volumn 98, Issue 7, 2006, Pages 1067-1070

  Cavus, Umut ^a,b   Coskun, Figen ^a,b   Yavuz, Bunyamin ^a,b   Ciftci, Orcun ^a,b   Sahiner, Levent ^a,b   Aksoy, Hakan ^a,b   Deniz, Ali ^a,b   Ozakin, Engin ^a,b   Aytemir, Kudret ^a,b   Tokgozoglu, Lale ^a,b   Kabakci, Giray ^a,b  

^a Faculty of Medicine ^*

^b HACETTEPE UNIVERSITY   (Turkey)

Author keywords

Acute coronary syndrome; Cardiac enzymes; Chest pain; Early diagnosis; H FABP

Indexed keywords

CREATINE KINASE MB; FATTY ACID BINDING PROTEIN; HEART TYPE FATTY ACID BINDING PROTEIN; MYOGLOBIN; TROPONIN; UNCLASSIFIED DRUG;

ACUTE CORONARY SYNDROME; ADULT; AGED; ARTICLE; EARLY DIAGNOSIS; ELECTROCARDIOGRAM; ENZYME ASSAY; FEMALE; HEART MUSCLE INJURY; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; POINT OF CARE TESTING; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; THORAX PAIN;

ACUTE DISEASE; ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; CHEST PAIN; CORONARY DISEASE; CREATINE KINASE, MB FORM; FATTY ACID-BINDING PROTEINS; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOGLOBIN; POINT-OF-CARE SYSTEMS; PROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; TIME FACTORS; TROPONIN;

EID: 33746684322     PISSN: 00279684     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Alhadi HA, Fox KAA. Do we need additional markers of myocyte necrosis?: the potential value of heart fatty acid binding protein. Q J Med. 2004;97:187-198.
2. Glatz JFC, Storch J. Unraveling the significance of cellular fatty acid binding proteins. Curr Opinion Lipidol. 2001;12:267-274.
3. Kragten JA, Van Nieuwenhoven FA, Van Dieijen-Visser MP, et al. Distribution of myoglobin and fatty acid binding protein in human cardiac autopsies. Clin Chem. 1996;42:337-338.
4. Van Nieuwenhoven FA, Kleine AH, Wodzig KW, et al. Discrimination between myocardium and skeletal muscle injury by assessment of the plasma ratio of myoglobin over fatty acid binding protein. Circulation. 1995;92:2848-2854.
5. Yoshimoto K, Tanaka T, Somiya K, et al. Human heart type cytoplasmic fatty acid binding protein as an indicator of acute myocardial infarction. Heart Vessels. 1995;10:304-309.
6. Braunwald E, Mark DB, Jones RH, et al. Unstable Angina: Diagnosis and Management. Clinical Practice Guideline No. 10 (amended). AHCPR Publication No. 94-0602. Rockville, MD: Agency for Health Care Policy and Research and the National Health, Lung and Blood Institute, Public Health Service, U.S. Department of Health and Human Services; 1994.
7. Glatz JF, Van Bilsen M, Paulussen RJ, et al. Release of fatty acid binding protein from isolated rat heart subjected to ischemia and reperfusion or to the calcium paradox. Biochim Biophys Acta. 1988;961:148-152.
8. Glatz JF, Van der Vusse GJ, Maessen JG, et al. Fatty acid-binding protein as marker of muscle injury: experimental finding and clinical application. Acta Anaesthesiol Scand Suppl. 1997;111:292-294.
9. Ishii J, Wang JH, Naruse H, et al. Serum concentration of myoglobin vs human heart-type cytoplasmic fatty acid binding protein in early detection of acute myocardial infarction. Clin Chem. 1997;43:1372-1378.
10. Mair J. Progress in myocardial damage detection: new biochemical markers for clinicians. Crit Rev Clin Lab Sci. 1997;34:1-66.
11. Kleine AH, Glatz JF, Van Nieuwenhoven FA, et al. Release of heart type fatty acid binding protein into plasma after AMI in man. Mol Cell Biochem. 1992;116:155-162.
12. Bakker AJ, Koelemay MJ, Gorgels JP, et al. Failure of new biochemical markers to exclude AMI at admission. Lancet. 1993;242:1220-1222.
13. Seino Y, Ogata K, Takano T, et al. Use of whole blood rapid panel test for heart type fatty acid-binding protein in patients with acute chest pain: comparison with rapid troponin T and myoglobin test. Am J Med. 2003;115:185-190.
14. Senio Y, Tomita Y, Takano T, et al. Office cardiologist study on whole blood rapid panel tests in patients with suspicious acute myocardial infarction. Comparison between heart type fatty acid-binding protein and troponin T tests. Circ J. 2004;68:144-148.
15. Sanders GT, Schouten Y, De Winter RJ, et al. Evaluation of human heart type fatty acid binding protein assay for early detection of myocardial infarction. Clin Chem. 1998;44:A132(abs).
16. Panteghini M, Bonora R, Pagani F, et al. Heart fatty acid binding protein in comparison with myoglobin for the early detection of acute myocardial infarction. Clin Chem. 1997;43:157 (abs).
17. Abe S, Saigo M, Yamashita T, et al. Heart fatty acid binding protein is useful in early and myocardial specific diagnosis of acute myocardial infarction. Circulation. 1996;94:1-323(abs).
18. Roberts M, Van der Hulst FF, Pelsers MMAL et al. Fatty acid binding protein as plasma marker of acute myocardial infarction: development of a rapid microparticle-enhanced turbidimetric immunoassay. Clin Chem. 1998;44:1564-1567.
19. Okamoto F, Sohmiya K, Ohkaru Y, et al. Human heart type cytoplasmic fatty acid binding protein for the diagnosis of acute myocardial infarction. Clinical evaluation of H-FABP in comparison with myoglobin and creatine kinase isoenzyme MB. Clin Chem Lab Med. 2000;38(3):231-238.
20. Seino Y, et al. Office Cardiologists Cooperative Study on Whole Blood Rapid Panel Tests in Patients With Suspicious Acute Myocardial Infarction Comparison Between Heart Type Fatty Acid Binding Protein and Troponin T Tests. Circ J. 2004;68:144-148.
21. Nakata T, et al. Human heart type fatty acid binding protein as an early diagnostic and prognostic marker in acute coronary syndrome. Cardiology. 2003;99:96-104.
22. Chan CPY, et al. Development of a quantitative lateral-flow assay for rapid detection of fatty acid binding protein. J Immunological Methods 2003;279:91-100.
23. Price CP. Point of care testing: clinical review. BMJ. 2001;322:1285-1288.
24. Junnichi I, et al. Serum concentrations of myoglobin vs. human heart type fatty acid binding protein in early detection of acute myocardial infarction. Clin Chem. 1997;43:1372-1378.
25. Glatz JFC, Hermens WT. Fatty acid binding protein as a plasma marker for the early assessment of individuals with acute coronary syndromes. Futura Publishing Co. Inc.: 2001.
26. Renneberg R, Cheng S, Wilhelmina AK, et al. Novel immunosensors for rapid diagnosis of acute myocardial infarction: a case report. Advances in Biosensors. 1999;4:241-272.
27. Gorski J, Hermens WT, Borawski J, et al. Increased fatty acid binding protein concentration in plasma of patients with chronic renal failure. Clin Chem. 1997;43:193-195.